Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer

被引:24
作者
Inamori, Koji [1 ,2 ,3 ,4 ,5 ]
Togashi, Yosuke [1 ]
Fukuoka, Shota [1 ]
Akagi, Kiwamu [6 ]
Ogasawara, Kouetsu [7 ]
Irie, Takuma [1 ]
Motooka, Daisuke [8 ]
Kobayashi, Yoichi [9 ,10 ]
Sugiyama, Daisuke [9 ]
Kojima, Motohiro [11 ]
Shiiya, Norihiko [3 ,4 ,5 ]
Nakamura, Shota [8 ]
Maruyama, Shoichi [10 ]
Suzuki, Yutaka [12 ]
Ito, Masaaki [2 ]
Nishikawa, Hiroyoshi [1 ,9 ]
机构
[1] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr EPOC, Div Canc Immunol, Res Inst, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Natl Canc Ctr Hosp East NCCHE, Dept Colorectal Surg, Chiba, Japan
[3] Hamamatsu Univ, Div Cardiovasc, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ, Div Thorac, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[5] Hamamatsu Univ, Div Gen Endoscop & Breast Surg, Surg 1, Sch Med, Hamamatsu, Shizuoka, Japan
[6] Saitama Canc Ctr SCC, Div Mol Diag & Canc Prevent, Saitama, Japan
[7] Tohoku Univ, Inst Dev Aging & Canc, Dept Immunobiol, Sendai, Miyagi, Japan
[8] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan
[9] Nagoya Univ, Grad Sch Med, Dept Immunol, Nagoya, Aichi, Japan
[10] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan
[11] NCCHE, Div Pathol, Chiba, Japan
[12] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan
关键词
REGULATORY T-CELLS; MICROSATELLITE INSTABILITY; PD-1; BLOCKADE; CLINICOPATHOLOGICAL FEATURES; EXPRESSION; TUMORS; COLON; INFILTRATION; MULTICENTER; IMMUNOLOGY;
D O I
10.1172/jci.insight.137365
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with colorectal cancers (CRCs) generally exhibit improved survival through intensive lymph node (LN) dissection. However, recent progress in cancer immunotherapy revisits the potential importance of regional LNs, where T cells are primed to attack tumor cells. To elucidate the role of regional LN, we investigated the immunological status of nonmetastatic regional LN lymphocytes (LNLs) in comparison with those of the tumor microenvironment (tumor-infiltrating lymphocytes; TILs) using flow cytometry and next-generation sequencing. LNLs comprised an intermediate level of the effector T cell population between peripheral blood lymphocytes (PBLs) and TILs. Significant overlap of the T cell receptor (TCR) repertoire was observed in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) CRCs with high tumor mutation burden (TMB), although limited TCRs were shared between nonmetastatic LNs and primary tumors in microsatellite stable/MMR proficient (MSS/pMMR) CRC patients with low TMB. In line with the overlap of the TCR repertoire, an excessive LN dissection did not provide a positive impact on long-term prognosis in our MSI-H/dMMR CRC cohort (n = 130). We propose that regional LNs play an important role in antitumor immunity, particularly in MSI-H/dMMR CRCs with high TMB, requiring care to be taken regarding excessive nonmetastatic LN dissection in MSI-H/dMMR CRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Decreasing Use of CT in Favor of Colonoscopy: A Retrospective Analysis of Post-Operative Imaging in Nonmetastatic dMMR/MSI-H Sporadic Colorectal Cancer
    Mi, Si-yuan
    Liao, Yi-jun
    Kang, Da
    Tang, Xin
    Chen, Gong
    Pan, Zhi-zhong
    Zhan, Jianhua
    Zhang, Rong-xin
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3814 - 3827
  • [32] Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States
    Aguiar-Ibanez, Raquel
    Hardern, Chloe
    van Hees, Frank
    Lee, Dawn
    Patel, Anubhav
    Chhabra, Nitika
    Baluni, Gargi
    Amonkar, Mayur
    Lai, Yizhen
    Xu, Ruifeng
    Massaad, Rachid
    Fogelman, David
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 469 - 480
  • [33] Complex pattern of immune evasion in MSI colorectal cancer
    Ozcan, Mine
    Janikovits, Jonas
    Doeberitz, Magnus von Knebel
    Kloor, Matthias
    ONCOIMMUNOLOGY, 2018, 7 (07):
  • [34] Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI-H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study
    Zhang, Xuan
    Yang, Renfang
    Wu, Tao
    Cai, Xinyi
    Li, Guoyu
    Yu, Kun
    Li, Yong
    Ding, Rong
    Dong, Chao
    Li, Jinsha
    Hu, Ruixi
    Feng, Qing
    Li, Yunfeng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Prognostic value of Lynch syndrome, BRAFV600E, and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts
    Zwart, Koen
    van Der Baan, Frederieke H.
    Cohen, Romain
    Aparicio, Thomas
    de la Fouchardiere, Christelle
    Lecomte, Thierry
    Punt, Cornelis J. A.
    Sefrioui, David
    Verheijden, Rik J.
    Vink, Geraldine R.
    Wensink, G. Emerens
    Zaanan, Aziz
    Koopman, Miriam
    Tougeron, David
    Roodhart, Jeanine M. L.
    CANCER MEDICINE, 2023, 12 (15): : 15841 - 15853
  • [36] Immune checkpoint inhibitors in luminal gastrointestinal malignancies: going beyond MSI-H/dMMR, TMB and PD-L1
    Lefler, Daniel S.
    Snook, Adam E.
    Bashir, Babar
    IMMUNOTHERAPY, 2022, 14 (11) : 885 - 902
  • [37] Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma
    Wang, Zhenghang
    Wang, Xinyu
    Xu, Yu
    Li, Jian
    Zhang, Xiaotian
    Peng, Zhi
    Hu, Yajie
    Zhao, Xinya
    Dong, Kun
    Zhang, Bei
    Gao, Chan
    Zhao, Xiaochen
    Chen, Hui
    Cai, Jinping
    Bai, Yuezong
    Sun, Yu
    Shen, Lin
    BMC MEDICINE, 2022, 20 (01)
  • [38] Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
    Tuninetti, Valentina
    Pace, Luca
    Ghisoni, Eleonora
    Quara, Virginia
    Arezzo, Francesca
    Palicelli, Andrea
    Mandato, Vincenzo Dario
    Geuna, Elena
    Cormio, Gennaro
    Biglia, Nicoletta
    Borsotti, Lucia
    Gallo, Silvia
    Ferrero, Annamaria
    Jacomuzzi, Elena
    Fuso, Luca
    Sanjinez, Jeremy Oscar Smith Pezua
    Puppo, Andrea
    Caglio, Andrea
    Rognone, Chiara
    Turinetto, Margherita
    Scotto, Giulia
    Di Maio, Massimo
    Valabrega, Giorgio
    CANCERS, 2023, 15 (14)
  • [39] Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report
    Varnier, Romain
    Garrivier, Thibaut
    Hafliger, Emilie
    Favre, Aymeric
    Coutzac, Clelia
    Spire, Clement
    Rochefort, Pauline
    Sarabi, Matthieu
    Desseigne, Francoise
    Guibert, Pierre
    Cattey-Javouhey, Anne
    Funk-Debleds, Pamela
    Mastier, Charles
    Buisson, Adrien
    Perol, David
    Tredan, Oliver
    Blay, Jean-Yves
    Phelip, Jean-Marc
    de la Fouchardiere, Christelle
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [40] Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
    Amonkar, Mayur M.
    Chase, Monica
    Myer, Nicole M.
    Wang, Tongtong
    Turzhitsky, Vladimir
    Spira, Alexander
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2023, 36